Cafepharma Today

May 21 2025 - Medtronic plans to separate its diabetes business into a new company
Medtronic plans to separate its diabetes business into a new company
Moderna shares down after pulling Covid-flu combo vaccine application
Roche's Genentech sticks with Orionis in 2nd molecular glue deal worth $2B
RFK Jr. takes fire in Senate hearing on research cuts
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Exelixis Deepens Profitable Ties to BMS
Seeking Alpha
Monday, October 18, 2010 - 9:41am
tags:
Bristol-Myers Squibb, Exelixis, diabetes, partnerships
Eli Lilly Scraps Late-Stage Head and Neck Cancer Drug: Biotech's Latest Tribulations
Seeking Alpha
Sunday, October 17, 2010 - 11:57am
tags:
Eli Lilly, Alimta, squamous cell cancer, head and neck cancer
GfK HealthCare Study: Physicians Ready to Accept New Oral Therapy for MS
Trading Markets
Sunday, October 17, 2010 - 11:54am
tags:
multiple sclerosis, Gilenya, Novartis
Washington Week: FDA Giveth, FDA Taketh Away
Medpagetoday.com
Sunday, October 17, 2010 - 11:34am
tags:
Botox, Menaflex, JZP-6, Girosa
Jazz Feels No Pain Following FDA Rejection
Seeking Alpha
Sunday, October 17, 2010 - 11:22am
tags:
JZP-6, fibromyalgia, Jazz Pharmaceuticals
Depomed: Long-Term Winner Holding Strong
Seeking Alpha
Sunday, October 17, 2010 - 11:20am
tags:
Depomed, Acuform
Is Johnson & Johnson a Sell?
Motley Fool
Sunday, October 17, 2010 - 11:17am
tags:
JNJ, investors
Johnson & Johnson ordered to pay $258M to La
Yahoo/AP
Sunday, October 17, 2010 - 11:16am
tags:
JNJ, Risperdal
Vivus Sells MUSE to Meda
Yahoo/Zacks
Sunday, October 17, 2010 - 11:11am
tags:
Vivus, Meda, Muse, erectile dysfunction
$3.78 Million Settlement Over SJS (Stevens Johnson Syndrome)Death of Nine-Year-Old Girl
Lawyers and Settlements
Saturday, October 16, 2010 - 10:46am
tags:
Stevens Johnson Syndrome, Dilantin, Pfizer, Flagyl, lawsuits
Early Initiation of Treatment with Copaxone (R) Provides Greater Effects in Delaying Conversion to Clinically Definite MS
Trading Markets
Saturday, October 16, 2010 - 9:41am
tags:
Copaxone, multiple sclerosis, Teva Pharmaceuticals
Dr. Reddy's announces the approval of Lansoprazole delayed-release capsules
MarketWatch
Saturday, October 16, 2010 - 9:39am
tags:
Dr Reddy's, Lansoprazole, Prevacid
Genzyme sues drug firm over wrinkle treatment
Boston Globe, MA
Saturday, October 16, 2010 - 9:18am
tags:
Genzyme, Restylane, Perlane, Medicis
Johnson & Johnson Loses Risperdal Suit in Louisiana
NY Times
Saturday, October 16, 2010 - 9:14am
tags:
JNJ, Risperdal
Celgene closes $2.9B acquisition of Abraxis
Yahoo/AP
Saturday, October 16, 2010 - 9:12am
tags:
Celgene, companies, M&A
Molecular Insight Surges on Trial Results
The Street
Saturday, October 16, 2010 - 9:11am
tags:
Molecular Insight, Trofex, diagnostic imaging
Promising Data on Amgen Drug
Yahoo/Zacks
Saturday, October 16, 2010 - 9:08am
tags:
Amgen, AMG 386, ovarian cancer
Celgene Completes Acquisition of Abraxis
Yahoo
Friday, October 15, 2010 - 12:34pm
tags:
Celgene, companies
Why Pharmathene Could Go From $2 to $20
Seeking Alpha
Friday, October 15, 2010 - 12:34pm
tags:
PharmAthene, Dendreon, Emergent BioSolutions, SIGA technologies, Genzyme, Gilead Sciences, Human Genome Sciences
Blackstone and Bain Plan Bids for Pfizer Capsule Unit
NY Times, NY
Friday, October 15, 2010 - 12:31pm
tags:
private equity, Pfizer, Capsugel

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.